Mixed Victory For Pfizer In Dutch Lipitor Battle
Pfizer said in a statement Wednesday that the District Court of The Hague in the Netherlands ruled that the basic patent for Lipitor would be infringed by Ranbaxy’s product. A second patent, however, was struck down.
The decision from the court’s three-judge panel prevents India-based Ranbaxy from launching a Dutch version...
To view the full article, register now.